An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

PHASE4RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 23, 2022

Primary Completion Date

September 23, 2025

Study Completion Date

October 23, 2025

Conditions
Hypersensitivity Pneumonitis
Interventions
DRUG

Mycophenolate Mofetil plus prednisolone

Prednisolone is a glucocorticoid that suppresses inflammation by several mechanisms. Mycophenolate mofetil (MMF) is an immunosuppressive drug that acts by inhibiting the proliferation of T-lymphocytes and suppressing the recruitment of lymphocytes and monocytes into the sites of inflammation.

DRUG

Prednisolone

Prednisolone is a glucocorticoid that suppresses inflammation by several mechanisms.

Trial Locations (1)

160012

RECRUITING

Postgraduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER